About X.J. Meng’s Research
Meng’s laboratory studies emerging, re-emerging and zoonotic viruses that are of human and veterinary public health importance. His research currently focuses on delineating the molecular mechanisms of viral pathogenesis and cross-species infection and developing effective viral vaccines.
Meng’s group discovered swine hepatitis E virus from pigs and avian hepatitis E viruses from chickens, which led to the recognition of human hepatitis E as a zoonotic disease. His lab also invented the first U.S. Department of Agriculture fully-licensed commercial vaccine, which is currently on the global market, against porcine circovirus type 2.
Meng is a member of the National Academy of Sciences (elected in 2016), a Fellow of the National Academy of Inventors (inducted in 2014), and a Fellow of the American Academy of Microbiology (elected in 2012).
- Hepatitis E virus (HEV)
- Porcine Circovirus (PCV)
- Porcine Reproductive and Respiratory Syndrome Virus (PRRSV)
- Torque Teno Sus Virus (TTSuV)
- Porcine Epidemic Diarrhea Virus (PEDV)
More details about these areas of research can be found on the Research Interests page.